Compare DIT & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DIT | CLNN |
|---|---|---|
| Founded | 1981 | 2012 |
| Country | United States | United States |
| Employees | N/A | 79 |
| Industry | Food Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.2M | 85.7M |
| IPO Year | 1996 | N/A |
| Metric | DIT | CLNN |
|---|---|---|
| Price | $81.08 | $6.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $33.75 |
| AVG Volume (30 Days) | 445.0 | ★ 671.8K |
| Earning Date | 04-20-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,392,388,157.00 | N/A |
| Revenue This Year | N/A | $17.64 |
| Revenue Next Year | N/A | $19,516.77 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.30 | N/A |
| 52 Week Low | $78.00 | $3.25 |
| 52 Week High | $126.50 | $13.50 |
| Indicator | DIT | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 37.06 | 43.31 |
| Support Level | $79.05 | $5.56 |
| Resistance Level | $120.08 | $6.92 |
| Average True Range (ATR) | 1.05 | 0.53 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 23.16 | 10.02 |
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.